1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane has been researched along with fulvestrant in 1 studies
*Fulvestrant: An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer. [MeSH]
*Fulvestrant: An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer. [MeSH]
| Studies (1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane) | Trials (1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane) | Recent Studies (post-2010) (1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane) | Studies (fulvestrant) | Trials (fulvestrant) | Recent Studies (post-2010) (fulvestrant) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 2,712 | 207 | 1,196 |
| Protein | Taxonomy | 1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane (IC50) | fulvestrant (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0061 | |
| Estrogen receptor | Rattus norvegicus (Norway rat) | 0.0059 | |
| Progesterone receptor | Homo sapiens (human) | 0.0002 | |
| Steroid hormone receptor ERR1 | Homo sapiens (human) | 0.002 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.006 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0104 | |
| Bile acid receptor | Homo sapiens (human) | 0.79 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abidi, SM; Dmytryk, JJ; Howard, EW; Pento, JT | 1 |
1 other study(ies) available for 1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane and fulvestrant
| Article | Year |
|---|---|
The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fibronectins; Fulvestrant; Humans; Neoplasm Invasiveness; Tamoxifen; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1998 |